Skip to content
This site requires JavaScript.
Toggle search
Toggle menu
Our Firm
About Lazard
Social Responsibility
History
Locations
175th Anniversary
Financial Advisory
Financial Advisory Overview
Strategic and M&A Advisory
Capital Markets Advisory
Restructuring & Liability Management
Specialized Advisory
Transactions
Asset Management
Asset Management Overview
Lazard Asset Management
Lazard Frères Gestion
The Edgewater Funds
Lazard Family Office Partners
People
Our People
Leadership & Board
Alumni
Investor Relations
Overview
Results & Reports
Corporate Sustainability Report (CSR)
Events & Presentations
Dividend History
Governance
SEC Filings
FAQs & Tax Info
Careers
Careers Overview
Job Search
Professionals
Students
Inclusion
Jobs Portal
Inside Lazard
Events
Research & Insights
All Research & Insights
Shareholder Activism
Levelized Cost of Energy+
News & Announcements
All News & Announcements
Lazard in the News
Media Contacts
Top suggestions
Our locations
Our people
Careers
News & Announcements
Lazard in the News
News & Announcements
Lazard in the News
Media Contacts
November 22, 2024
Lazard Chief Market Strategist Ron Temple on CNBC's Money Movers
Read more
Filter
Clear all
Clear
Apply Filter
SELECTED FILTERS
Clear all
Location
London
New York
Topic
Ronald Temple
Capital Advisory
Shareholder Activism
Shareholder Advisory
LCOE
Market Commentary
Leadership
Healthcare
Levelized Cost of Energy
Year
2023
2024
Showing 1 to 5 of 54 Results
November 14, 2024
Lazard Chief Executive Officer Peter Orszag Authors Oped in The Washington Post
November 11, 2024
Lazard Chief Executive Officer Peter Orszag on CNBC’s Squawk Box
October 31, 2024
Lazard Chief Executive Officer Peter Orszag on CNBC’s Money Movers
October 18, 2024
Lazard’s Global Co-Heads of Biopharma, Dale Raine and Michael Kingston, Appear on The BioCentury Show
1
2
3
...
11
←
→
